Protective immunity in hamsters from an oral Nipah vaccine correlates with pseudovirus neutralising antibody titre

Abstract Nipah virus (NiV) is a deadly zoonotic pathogen with a high mortality rate and no approved vaccines, creating an urgent need for new solutions. We developed a novel, thermostable, orally administered NiV vaccine using a human serotype 5 adenovirus (AdHu5) vector to express NiV glycoproteins...

Descrición completa

Detalles Bibliográficos

Principais autores:	Meredith Stewart, Peter Bone, Andrew Bacon, Golnaz Emami, Lauren Cave, Elliot J. Bland, Stuart Dowall, Linda Easterbrook, Stephen Findlay-Wilson, Susan Fotheringham, Emma Kennedy, Ines Ruedas-Torres, Francisco J. Salguero, Craig Laferriere, Jeff Drew
Formato:	Artigo
Idioma:	Inglês
Publicado:	Nature Portfolio 2026-04-01
Series:	Scientific Reports
Acceso en liña:	https://doi.org/10.1038/s41598-026-40205-2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!